194 related articles for article (PubMed ID: 11291579)
21. In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period.
Kucukates E; Erturan Z; Susever S; Yegenoglu Y
APMIS; 2005 Apr; 113(4):278-83. PubMed ID: 15865609
[TBL] [Abstract][Full Text] [Related]
22. Management of deep Candida infection in surgical and intensive care unit patients. British Society for Antimicrobial Chemotherapy Working Party.
Intensive Care Med; 1994 Aug; 20(7):522-8. PubMed ID: 7995872
[TBL] [Abstract][Full Text] [Related]
23. Clinical consequences of resistant Candida infections in intensive care.
Montravers P; Jabbour K
Int J Antimicrob Agents; 2006 Jan; 27(1):1-6. PubMed ID: 16343859
[TBL] [Abstract][Full Text] [Related]
24. [Candida-specific antibodies in intensive care and non-intensive care patients].
Knoke M; Bernhardt H
Mycoses; 2004; 47 Suppl 1():19-22. PubMed ID: 15667359
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of Candida species in different hospital wards and their susceptibility to antifungal agents: results of a three year survey.
Fadda ME; Podda GS; Pisano MB; Deplano M; Cosentino S
J Prev Med Hyg; 2008 Jun; 49(2):69-74. PubMed ID: 18847180
[TBL] [Abstract][Full Text] [Related]
26. [The use of fluconazole in low-weight neonates with candidiasis].
Saporito N; Tina LG; Betta P; Sciacca A
Pediatr Med Chir; 1994; 16(3):263-7. PubMed ID: 7971450
[TBL] [Abstract][Full Text] [Related]
27. Candidemia in neonatal intensive care unit.
Gupta N; Mittal N; Sood P; Kumar S; Kaur R; Mathur MD
Indian J Pathol Microbiol; 2001 Jan; 44(1):45-8. PubMed ID: 12561995
[TBL] [Abstract][Full Text] [Related]
28. [Candida infections in intensive care patients].
Füssle R; Bicoping J; Michaelis G; Sziegoleit A
Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Nov; 26(7):395-7. PubMed ID: 1772939
[TBL] [Abstract][Full Text] [Related]
29. Candida parapsilosis: two cases of endocarditis in association with the Toronto stentless porcine valve.
Jones JM; Sarsam MA; Clarke MA; Hedderwick SA
J Infect; 2002 Apr; 44(3):196-8. PubMed ID: 12099751
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis of systemic Candida infections in patients of the intensive care unit. Significance of serum antigens and antibodies.
Bär W; Hecker H
Mycoses; 2002 Feb; 45(1-2):22-8. PubMed ID: 11856433
[TBL] [Abstract][Full Text] [Related]
31. Vulvovaginal candidiasis in a Flemish patient population.
De Vos MM; Cuenca-Estrella M; Boekhout T; Theelen B; Matthijs N; Bauters T; Nailis H; Dhont MA; Rodriguez-Tudela JL; Nelis HJ
Clin Microbiol Infect; 2005 Dec; 11(12):1005-11. PubMed ID: 16307555
[TBL] [Abstract][Full Text] [Related]
32. Preemptive therapy in nonneutropenic patients with Candida infection using the Japanese guidelines.
Tsuruta R; Mizuno H; Kaneko T; Oda Y; Kaneda K; Fujita M; Inoue T; Kasaoka S; Maekawa T
Ann Pharmacother; 2007 Jul; 41(7):1137-43. PubMed ID: 17535843
[TBL] [Abstract][Full Text] [Related]
33. Consensus statement on the management of invasive candidiasis in Intensive Care Units in the Asia-Pacific Region.
Hsueh PR; Graybill JR; Playford EG; Watcharananan SP; Oh MD; Ja'alam K; Huang S; Nangia V; Kurup A; Padiglione AA
Int J Antimicrob Agents; 2009 Sep; 34(3):205-9. PubMed ID: 19409759
[TBL] [Abstract][Full Text] [Related]
34. Oral amphotericin B for the prevention of Candida bloodstream infection in critically ill children.
Ben-Ari J; Samra Z; Nahum E; Levy I; Ashkenazi S; Schonfeld TM
Pediatr Crit Care Med; 2006 Mar; 7(2):115-8. PubMed ID: 16474259
[TBL] [Abstract][Full Text] [Related]
35. Antifungal therapy for neonatal candidiasis.
Zaoutis T; Walsh TJ
Curr Opin Infect Dis; 2007 Dec; 20(6):592-7. PubMed ID: 17975409
[TBL] [Abstract][Full Text] [Related]
36. Fluconazole in combination with flucytosine in the treatment of fluconazole-resistant Candida infections.
Girmenia C; Venditti M; Martino P
Diagn Microbiol Infect Dis; 2003 Jul; 46(3):227-31. PubMed ID: 12867100
[TBL] [Abstract][Full Text] [Related]
37. Impact of fluconazole administration on outcomes in critically ill patients.
Garrelts JC; Schroeder TR; Harrison PB
Ann Pharmacother; 2004 Oct; 38(10):1588-92. PubMed ID: 15340132
[TBL] [Abstract][Full Text] [Related]
38. [Advances in the diagnosis and treatment of yeast infections: role of the new antifungal agents].
Pemán J; Almirante B
Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 13():38-46. PubMed ID: 19100166
[TBL] [Abstract][Full Text] [Related]
39. Treatment of severe Candida infections in high-risk patients in Germany: consensus formed by a panel of interdisciplinary investigators.
Büchner T; Fegeler W; Bernhardt H; Brockmeyer N; Duswald KH; Herrmann M; Heuser D; Jehn U; Just-Nübling G; Karthaus M; Maschmeyer G; Müller FM; Müller J; Ritter J; Roos N; Ruhnke M; Schmalreck A; Schwarze R; Schwesinger G; Silling G;
Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):337-52. PubMed ID: 12072918
[TBL] [Abstract][Full Text] [Related]
40. Host immune reactivity determines the efficacy of combination immunotherapy and antifungal chemotherapy in candidiasis.
Mencacci A; Cenci E; Bacci A; Bistoni F; Romani L
J Infect Dis; 2000 Feb; 181(2):686-94. PubMed ID: 10669356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
